BIOMAT Database Logo BIOMAT Database Logo

Synthesis and mechanism of action of novel pyrimidinyl pyrazole derivatives possessing antiproliferative activity. 2002

Hitoshi Ohki, and Kenji Hirotani, and Hiroyuki Naito, and Satoru Ohsuki, and Megumi Minami, and Akio Ejima, and Yukiko Koiso, and Yuichi Hashimoto
Medicinal Chemistry Research Laboratory, Daiichi Pharmaceutical Co. Ltd., 16-13, Kita-kasai 1-chome, Edogawa-ku, 134, Tokyo, Japan. okihi10g@daiichipharm.co.jp

Pyrimidinyl pyrazole derivatives 1-4, prepared as a new scaffold of an anti-tumor agent, showed antiproliferative activity against human lung cancer cell lines and inhibited tubulin polymerization. Furthermore, it was found that compound 2 bound at the colchicine site on tubulin, but the tubulin binding pattern was different from that of colchicine. Here, we describe the synthesis of the derivatives and the differences of the action mechanism on tubulin polymerization inhibition between compound 2 and colchicine.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008870 Microtubules Slender, cylindrical filaments found in the cytoskeleton of plant and animal cells. They are composed of the protein TUBULIN and are influenced by TUBULIN MODULATORS. Microtubule
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D003078 Colchicine A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE). Colchicine, (+-)-Isomer,Colchicine, (R)-Isomer
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

Hitoshi Ohki, and Kenji Hirotani, and Hiroyuki Naito, and Satoru Ohsuki, and Megumi Minami, and Akio Ejima, and Yukiko Koiso, and Yuichi Hashimoto
Antiproliferative activity and mechanism of action of DZ-3358, a novel pyrimidinyl pyrazole derivative.
January 2000, Anticancer research,
Hitoshi Ohki, and Kenji Hirotani, and Hiroyuki Naito, and Satoru Ohsuki, and Megumi Minami, and Akio Ejima, and Yukiko Koiso, and Yuichi Hashimoto
Synthesis and antitumor activity of novel pyrimidinyl pyrazole derivatives.
December 1999, Chemical & pharmaceutical bulletin,
Hitoshi Ohki, and Kenji Hirotani, and Hiroyuki Naito, and Satoru Ohsuki, and Megumi Minami, and Akio Ejima, and Yukiko Koiso, and Yuichi Hashimoto
Synthesis and antitumor activity of novel pyrimidinyl pyrazole derivatives. III. Synthesis and antitumor activity of 3-phenylpiperazinyl-1-trans-propenes.
February 2005, Chemical & pharmaceutical bulletin,
Hitoshi Ohki, and Kenji Hirotani, and Hiroyuki Naito, and Satoru Ohsuki, and Megumi Minami, and Akio Ejima, and Yukiko Koiso, and Yuichi Hashimoto
One-Pot Synthesis and Antiproliferative Activity of Highly Functionalized Pyrazole Derivatives.
March 2022, ChemMedChem,
Hitoshi Ohki, and Kenji Hirotani, and Hiroyuki Naito, and Satoru Ohsuki, and Megumi Minami, and Akio Ejima, and Yukiko Koiso, and Yuichi Hashimoto
Antiproliferative Activity of New Pyrazole-4-sulfonamide Derivatives: Synthesis and Biological Evaluation.
July 2023, ACS omega,
Hitoshi Ohki, and Kenji Hirotani, and Hiroyuki Naito, and Satoru Ohsuki, and Megumi Minami, and Akio Ejima, and Yukiko Koiso, and Yuichi Hashimoto
Synthesis and antiproliferative activity of novel selenoester derivatives.
February 2014, European journal of medicinal chemistry,
Hitoshi Ohki, and Kenji Hirotani, and Hiroyuki Naito, and Satoru Ohsuki, and Megumi Minami, and Akio Ejima, and Yukiko Koiso, and Yuichi Hashimoto
Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
January 2015, European journal of medicinal chemistry,
Hitoshi Ohki, and Kenji Hirotani, and Hiroyuki Naito, and Satoru Ohsuki, and Megumi Minami, and Akio Ejima, and Yukiko Koiso, and Yuichi Hashimoto
Synthesis and broad-spectrum antiproliferative activity of diarylamides and diarylureas possessing 1,3,4-oxadiazole derivatives.
April 2015, Bioorganic & medicinal chemistry letters,
Hitoshi Ohki, and Kenji Hirotani, and Hiroyuki Naito, and Satoru Ohsuki, and Megumi Minami, and Akio Ejima, and Yukiko Koiso, and Yuichi Hashimoto
[Synthesis and antibacterial activity of pyrimidinyl sulfanilamide derivatives].
April 1967, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Hitoshi Ohki, and Kenji Hirotani, and Hiroyuki Naito, and Satoru Ohsuki, and Megumi Minami, and Akio Ejima, and Yukiko Koiso, and Yuichi Hashimoto
Novel pyrazole derivatives: synthesis and evaluation of anti-angiogenic activity.
June 2010, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!